These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8119606)

  • 1. [The effect of the early administration of progesterone on egg recovery, fertilization and pregnancy in an institutional fertilization in vitro program].
    Carranza Lira S; Kably Ambe A; Espinosa de los Monteros AE; di Castro Stringher P; Villanueva Díaz C; Alvarado Durán A
    Ginecol Obstet Mex; 1993 Dec; 61():351-5. PubMed ID: 8119606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delaying the initiation of progesterone supplementation until the day of fertilization does not compromise cycle outcome in patients receiving donated oocytes: a randomized study.
    Escribá MJ; Bellver J; Bosch E; Sánchez M; Pellicer A; Remohí J
    Fertil Steril; 2006 Jul; 86(1):92-7. PubMed ID: 16818032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of early luteal-phase vaginal progesterone supplementation on the outcome of in vitro fertilization and embryo transfer.
    Mui Lam P; Chun Cheung M; Ping Cheung L; Ingrid Lok H; John Haines C
    Gynecol Endocrinol; 2008 Dec; 24(12):674-80. PubMed ID: 19172535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dosage of human chorionic gonadotropins influences the relationship between progesterone and cycle outcome during in vitro fertilization-embryo transfer.
    Prien SD; Canez MS; Messer RH
    Int J Fertil Womens Med; 2000; 45(4):258-63. PubMed ID: 10997481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization.
    Kovacs P; Kovats T; Bernard A; Zadori J; Szmatona G; Kaali SG
    Fertil Steril; 2008 Dec; 90(6):2133-7. PubMed ID: 18177866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum progesterone at human chorionic gonadotropin injection significantly correlate with female age.
    Doldi N; Persico P; De Santis L; Rabellotti E; Papaleo E; Ferrari A
    Minerva Ginecol; 2005 Aug; 57(4):477-82. PubMed ID: 16170294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo maturation of oocytes by extending the interval between human chorionic gonadotropin administration and oocyte retrieval.
    Raziel A; Schachter M; Strassburger D; Kasterstein E; Ron-El R; Friedler S
    Fertil Steril; 2006 Sep; 86(3):583-7. PubMed ID: 16828475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timing luteal phase support in GnRH agonist down-regulated IVF/embryo transfer cycles.
    Mochtar MH; Van Wely M; Van der Veen F
    Hum Reprod; 2006 Apr; 21(4):905-8. PubMed ID: 16373409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian stimulation with daily late follicular phase administration of low-dose human chorionic gonadotropin for in vitro fertilization: a prospective, randomized trial.
    Serafini P; Yadid I; Motta EL; Alegretti JR; Fioravanti J; Coslovsky M
    Fertil Steril; 2006 Oct; 86(4):830-8. PubMed ID: 16963040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective, randomized study to evaluate the success rates using hCG, vaginal progesterone or a combination of both for luteal phase support.
    Ludwig M; Finas A; Katalinic A; Strik D; Kowalcek I; Schwartz P; Felberbaum R; Küpker W; Schöpper B; Al-Hasani S; Diedrich K
    Acta Obstet Gynecol Scand; 2001 Jun; 80(6):574-82. PubMed ID: 11380297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring estradiol levels after human chorionic gonadotropin administration for in vitro fertilization is not clinically useful.
    Chiasson MD; Bates GW; Robinson RD; Arthur NJ; Propst AM
    Fertil Steril; 2007 Feb; 87(2):448-50. PubMed ID: 17084395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estradiol supplementation during the luteal phase of IVF-ICSI patients: a randomized, controlled trial.
    Serna J; Cholquevilque JL; Cela V; Martínez-Salazar J; Requena A; Garcia-Velasco JA
    Fertil Steril; 2008 Dec; 90(6):2190-5. PubMed ID: 18191847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists.
    Kolibianakis EM; Schultze-Mosgau A; Schroer A; van Steirteghem A; Devroey P; Diedrich K; Griesinger G
    Hum Reprod; 2005 Oct; 20(10):2887-92. PubMed ID: 15979994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of pelvic inflammatory disease grades on in vitro fertilization-embryo transfer outcome].
    Yang XE; Zhang SY
    Zhonghua Fu Chan Ke Za Zhi; 2007 Oct; 42(10):666-9. PubMed ID: 18241540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.
    Humaidan P; Bredkjaer HE; Bungum L; Bungum M; Grøndahl ML; Westergaard L; Andersen CY
    Hum Reprod; 2005 May; 20(5):1213-20. PubMed ID: 15760966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing the dose of human chorionic gonadotropin in high responders does not affect the outcomes of in vitro fertilization.
    Schmidt DW; Maier DB; Nulsen JC; Benadiva CA
    Fertil Steril; 2004 Oct; 82(4):841-6. PubMed ID: 15482757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can pregnancy rate be improved in gonadotropin-releasing hormone (GnRH) antagonist cycles by administering GnRH agonist before oocyte retrieval? A prospective, randomized study.
    Schachter M; Friedler S; Ron-El R; Zimmerman AL; Strassburger D; Bern O; Raziel A
    Fertil Steril; 2008 Oct; 90(4):1087-93. PubMed ID: 18023439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum estradiol the day of hCG administration as predictor factor of IVF-ET].
    Kably Ambe A; Estévez González S; Carballo Mondragón E
    Ginecol Obstet Mex; 2008 Apr; 76(4):197-201. PubMed ID: 18798418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of low-dose pre-ovulatory progesterone administration on the outcome of in-vitro fertilization (IVF) and intra-tubal gamete transfer (GIFT)].
    Bernt WD; Pilka L; Sudik R; Texl P; Krzyzanowski A; Jirasková D; Fliess FR
    Zentralbl Gynakol; 1990; 112(8):481-7. PubMed ID: 2363319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does pre-treatment with micronized progesterone affect the ovarian response to a gonadotropin releasing hormone agonist flare-up protocol?
    Loutradis D; Stefanidis K; Drakakis P; Kallianidis K; El Sheikh A; Milingos S; Siskos K; Michalas S
    Gynecol Endocrinol; 2003 Apr; 17(2):101-6. PubMed ID: 12737670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.